Five therapeutic areas that are apt for an all-virtual approach, and that can serve as an entry point for sponsors who are hesitant yet interested in exploring the growing DCT model.

News

uMotif Collaborates with The University of Manchester on Body Mapping Tool

EPAM Debuts Cloud-Powered Digital Trials Platform

People and Business News — 11/21

Emmes and MedGenome Launch Genomics Strategic Rare Disease Research Partnership

ICON Announces the Expansion of its Accellacare Site Network

MediCapital Rent Is Now Emsere

Emmes Launches Orphan Reach

KPS Life Opens European Headquarters in Poland

Clinical Ink Acquires Digital Artefacts

Clinical Cancer Research Publishes Review of Regulatory Real-World Evidence in Successful Oncology Product Approvals

THREAD Acquires Modus Outcomes

ERT and Bioclinica Become Clario

Science 37 Doubles Down on DCT Collaborations in Japan/APAC

Diversity of Site Staff Highly Associated with Diversity of Patients Enrolled Trials, According to Tufts

inVibe’s Labs Introduces TrialPulse

SWOG CTP Selects Florence Healthcare to Support Trial Operations

SGS Increases Biosafety Testing Capacity at Glasgow Facility

Catalent Opens New Facility in San Diego

Florence Launches Digital Clinical Research Certification Program

Hospital Pablo Tobón Uribe Joins Clinerion’s Patient Network Explorer

SGS Opens New Site in Belgium

Imaging Endpoints Establishes Operations in Shanghai

Trialbee Announces Trialbee Honey

Pandemic-Driven Changes in Pharma Here to Stay as New Clinical Trial Models Take Hold

Advarra Announces Site IQ

Calyx RIM Selected by Top 10 Global Pharma Company

Industry Update: Highlights from DPHARM 2021

University College London Hospitals Collaborate with AstraZeneca and IgniteData to Test SMART ON FHIR Based Tech

THREAD Expands into EMEA Market

Decentralized Clinical Trials: What Therapeutic Areas are Ripe for All-Virtual?

Trending on Applied Clinical Trials Online

Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It

Real-World Evidence Is Moving Upstream: Is the Data Infrastructure Ready?

The Data Inputs That Matter Most When Pressure-Testing a Protocol's Feasibility

ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval

How AI Is Changing Endpoint Selection Before a Trial Even Starts